Literature DB >> 20138874

Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design.

Andrew W Taylor-Robinson1.   

Abstract

Malaria, a disease caused by the protozoan parasite Plasmodium, remains a serious healthcare problem in developing countries worldwide. While the host-parasite relationship in humans has been difficult to determine, the pliability of murine malaria models has enabled valuable contributions to the understanding of the pathogenesis of disease. Although no single model reflects precisely malaria infection of the human, different models collectively provide important information on the mechanisms of protective immunity and immunopathogenesis. This review summarizes progress towards understanding the broad spectrum of immune responsiveness to the blood stages of the malaria parasite during experimental infections in mice and highlights how examination of murine malarias sheds light on the factors involved in the modulation of vaccine-potentiated immunity. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138874     DOI: 10.1016/j.exppara.2010.01.028

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  17 in total

1.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii.

Authors:  Anmol Chandele; Paushali Mukerjee; Gobardhan Das; Rafi Ahmed; Virander S Chauhan
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

Review 3.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

4.  The course of a primary infection of Plasmodium yoelii 17XL in both 129S1 and IFN-γ receptor-deficient mice.

Authors:  Akira Ishih; Toshi Nagata; Fumie Kobayashi
Journal:  Parasitol Res       Date:  2012-03-06       Impact factor: 2.289

5.  Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites.

Authors:  Noah S Butler; Nathan W Schmidt; Ashley M Vaughan; Ahmed S Aly; Stefan H I Kappe; John T Harty
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

6.  Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.

Authors:  Akira Ishih; Chiri Kawakami; Atsuko Todoroki; Hiroya Hirai; Kaneo Ohori; Fumie Kobayashi
Journal:  Parasitol Res       Date:  2012-11-21       Impact factor: 2.289

7.  Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.

Authors:  Sumi Biswas; Alexandra J Spencer; Emily K Forbes; Sarah C Gilbert; Anthony A Holder; Adrian V S Hill; Simon J Draper
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

8.  Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.

Authors:  Sumi Biswas; Matthew D J Dicks; Carole A Long; Edmond J Remarque; Loredana Siani; Stefano Colloca; Matthew G Cottingham; Anthony A Holder; Sarah C Gilbert; Adrian V S Hill; Simon J Draper
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

9.  Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.

Authors:  Elizabeth G Kane; Andrew W Taylor-Robinson
Journal:  Malar Res Treat       Date:  2012-01-18

10.  Insufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout mice.

Authors:  Nathalie Geurts; Erik Martens; Sebastien Verhenne; Natacha Lays; Greet Thijs; Stefan Magez; Bénédicte Cauwe; Sandra Li; Hubertine Heremans; Ghislain Opdenakker; Philippe E Van den Steen
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.